Growth Metrics

Idexx Laboratories (IDXX) Shares Outstanding (Diluted Average) (2016 - 2025)

Idexx Laboratories has reported Shares Outstanding (Diluted Average) over the past 13 years, most recently at $81.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $81.0 million for Q4 2025, down 2.67% from a year ago — trailing twelve months through Dec 2025 was $81.0 million (down 2.67% YoY), and the annual figure for FY2025 was $81.0 million, down 2.67%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $81.0 million at Idexx Laboratories, roughly flat from $81.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for IDXX hit a ceiling of $86.9 million in Q1 2021 and a floor of $81.0 million in Q2 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $84.0 million (2023), compared with a mean of $84.1 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.24% in 2021 and later fell 2.88% in 2025.
  • Idexx Laboratories' Shares Outstanding (Diluted Average) stood at $86.6 million in 2021, then dropped by 2.28% to $84.6 million in 2022, then dropped by 0.74% to $84.0 million in 2023, then dropped by 0.87% to $83.2 million in 2024, then fell by 2.67% to $81.0 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $81.0 million (Q4 2025), $81.2 million (Q3 2025), and $81.0 million (Q2 2025) per Business Quant data.